GUIAS ALAD DIABETES 2010 PDF
GUÍAS ALAD People with Type 2 diabetes now have personalized treatment options Genetic factors tied to obesity may protect against diabetes. OPS. Guias ALAD de diagnostico, control y tratamiento de la Diabetes Mellitus Tipo 2, (In Spanish) Veracruz Initiative for Diabetes Awareness, Barcelo A, Jawed M, Qiang A. PAHO Diabetes Guideline Project Group. .. Guías ALAD sobre el diagnóstico, control y tratamiento de la diabetes .. Guía clínica de diabetes tipo 2. Santiago: MINSAL;. Available from:
|Published (Last):||5 December 2008|
|PDF File Size:||13.73 Mb|
|ePub File Size:||10.59 Mb|
|Price:||Free* [*Free Regsitration Required]|
Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus. The Finnish Diabetes Prevention Study.
American Diabetes Association®
Bariatric surgery versus intensive medical fiabetes for diabetesyear outcomes. A meta-analysis of randomised controlled trials RCT among healthy normotensive and essential hypertensive elderly patients to determine the effect of high salt NaCl diet on blood pressure.
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. Beneficial effect on average lipid levels from energy restriction and fat loss in obese individuals with or without type 2 diabetes.
Diabetes Care, ; Maternal efficacy and safety outcomes in a aalad, controlled trial comparing insulin detemir with NPH insulin in pregnant women with type 1 diabetes. Kidney Int ; Approaches to treatment of type 2 diabetes. Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids: Chronic noncommunicable diseases are an important dabetes of morbidity and are responsible for two-thirds of the total deaths in our Region.
Sodium-glucose cotransporter-2 inhibition and the potential for renal protection in diabetic nephropathy.
Diabetes: Scientific and Technical Material
J Clin Guiaa Metab. Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: High-monounsaturated-fat diets for patients with diabetes mellitus: Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
Diabetes Metab Res Rev ; Over the past decade it has been obvious that the prevalence of type 2 diabetes is increasing rapidly. De Fronzo R, et al. A multicentre, randomised, open-label trial. The goal of the U. Effect of aerobic exercise on giuas pressure: Am J Med ; J Clin Endocrinol Metab Curr Opin Nephrol Hypertens ; Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide.
Options for combination therapy in type 2 diabetes: The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
Revista de la ALAD, Management of hyperglycemia in type 2 diabetes, A randomised four-intervention crossover study investigating the effect of carbohydrates on daytime profiles of insulin, glucose, non-esterified fatty acids and triacylglycerols in middle-aged men.
Fritsche A, Haring H.
Curr Med Opin ; Dipeptidylpeptidase 4 DPP-4 inhibitors for type 2 diabetes mellitus. Cochrane Data base Syst, In the late s both WHO and the NAtional Diabetes Data Group produced new diagnostic criteria and a new classification system for diabetes mellitus. Alam S, Johnson AG. Dose response relation between sulfonylureas drugs and mortality in type 2 diabetes.
Management of hyperglycemia in type 2 diabetes: Revista de la ALAD ; 3: Comparison of high and lowglycemicindex breakfast cereals with monounsaturated fat in the long-term dietary management of type 2 diabetes. Am J Clin Nutr ; Diabetes and hypertension are two closely related chronic diseases that have been recognized as significant threats to the health and economic well being of socioeconomically developed countries such as those of North America and Europe.
Ann Intern Med Herman W, et al. Veracruz Initiative for Diabetes Awareness, Chronic noncommunicable diseases are an important source of morbidity and are responsible for two-thirds of the total deaths in our Region.